| The development of vaccine viruses against pandemic A (H1N1) influenza JS Robertson, C Nicolson, R Harvey, R Johnson, D Major, K Guilfoyle, ... Vaccine 29 (9), 1836-1843, 2011 | 130 | 2011 |
| M2e-based universal influenza vaccines: a historical overview and new approaches to development D Mezhenskaya, I Isakova-Sivak, L Rudenko Journal of biomedical science 26 (1), 76, 2019 | 117 | 2019 |
| Genetic bases of the temperature-sensitive phenotype of a master donor virus used in live attenuated influenza vaccines: A/Leningrad/134/17/57 (H2N2) I Isakova-Sivak, LM Chen, Y Matsuoka, JTM Voeten, I Kiseleva, ... Virology 412 (2), 297-305, 2011 | 95 | 2011 |
| Assessment of human immune responses to H7 avian influenza virus of pandemic potential: Results from a placebo–controlled, randomized double–blind phase I study of live … L Rudenko, I Kiseleva, AN Naykhin, M Erofeeva, M Stukova, S Donina, ... PloS one 9 (2), e87962, 2014 | 64 | 2014 |
| Basics of CD8 T-cell immune responses after influenza infection and vaccination with inactivated or live attenuated influenza vaccine D Korenkov, I Isakova-Sivak, L Rudenko Expert review of vaccines 17 (11), 977-987, 2018 | 62 | 2018 |
| Development and approval of live attenuated influenza vaccines based on Russian master donor viruses: Process challenges and success stories L Rudenko, L Yeolekar, I Kiseleva, I Isakova-Sivak Vaccine 34 (45), 5436-5441, 2016 | 61 | 2016 |
| Comparative immunogenicity and cross-clade protective efficacy of mammalian cell-grown inactivated and live attenuated H5N1 reassortant vaccines in ferrets KM Gustin, TR Maines, JA Belser, N van Hoeven, X Lu, L Dong, ... Journal of Infectious Diseases 204 (10), 1491-1499, 2011 | 55 | 2011 |
| H7N9 live attenuated influenza vaccine in healthy adults: a randomised, double-blind, placebo-controlled, phase 1 trial L Rudenko, I Isakova-Sivak, A Naykhin, I Kiseleva, M Stukova, M Erofeeva, ... The Lancet Infectious Diseases 16 (3), 303-310, 2016 | 49 | 2016 |
| Safety, immunogenicity and infectivity of new live attenuated influenza vaccines I Isakova-Sivak, L Rudenko Expert Review of Vaccines 14 (10), 1313-1329, 2015 | 45 | 2015 |
| Broadly protective anti-hemagglutinin stalk antibodies induced by live attenuated influenza vaccine expressing chimeric hemagglutinin I Isakova-Sivak, D Korenkov, T Smolonogina, T Kotomina, S Donina, ... Virology 518, 313-323, 2018 | 40 | 2018 |
| H7N9 live attenuated influenza vaccine is highly immunogenic, prevents virus replication, and protects against severe bronchopneumonia in ferrets J De Jonge, I Isakova-Sivak, H Van Dijken, S Spijkers, J Mouthaan, ... Molecular Therapy 24 (5), 991-1002, 2016 | 38 | 2016 |
| H7N3 live attenuated influenza vaccine has a potential to protect against new H7N9 avian influenza virus L Rudenko, I Isakova-Sivak, S Donina Vaccine 31 (42), 4702-4705, 2013 | 38 | 2013 |
| Development and pre-clinical evaluation of two LAIV strains against potentially pandemic H2N2 influenza virus I Isakova-Sivak, J de Jonge, T Smolonogina, A Rekstin, G van Amerongen, ... PloS one 9 (7), e102339, 2014 | 30 | 2014 |
| Influenza vaccine: Progress in a vaccine that elicits a broad immune response I Isakova-Sivak, E Stepanova, D Mezhenskaya, V Matyushenko, ... Expert Review of Vaccines 20 (9), 1097-1112, 2021 | 29 | 2021 |
| Conserved T-cell epitopes of respiratory syncytial virus (RSV) delivered by recombinant live attenuated influenza vaccine viruses efficiently induce RSV-specific lung-localized … V Matyushenko, T Kotomina, I Kudryavtsev, D Mezhenskaya, ... Antiviral Research 182, 104864, 2020 | 28 | 2020 |
| Recombinant live attenuated influenza vaccine viruses carrying CD8 T-cell epitopes of respiratory syncytial virus protect mice against both pathogens without inflammatory disease T Kotomina, I Isakova-Sivak, V Matyushenko, KH Kim, Y Lee, YJ Jung, ... Antiviral research 168, 9-17, 2019 | 28 | 2019 |
| Characterization of reverse genetics-derived cold-adapted master donor virus a/Leningrad/134/17/57 (H2N2) and reassortants with H5N1 surface genes in a mouse model I Isakova-Sivak, LM Chen, M Bourgeois, Y Matsuoka, JTM Voeten, ... Clinical and Vaccine Immunology 21 (5), 722-731, 2014 | 28 | 2014 |
| A promising inactivated whole-virion SARS-CoV-2 vaccine I Isakova-Sivak, L Rudenko The Lancet Infectious Diseases 21 (1), 2-3, 2021 | 27 | 2021 |
| Sequential immunization with universal live attenuated influenza vaccine candidates protects ferrets against a high-dose heterologous virus challenge I Isakova-Sivak, V Matyushenko, T Kotomina, I Kiseleva, E Krutikova, ... Vaccines 7 (3), 61, 2019 | 27 | 2019 |
| Comparative studies of infectivity, immunogenicity and cross-protective efficacy of live attenuated influenza vaccines containing nucleoprotein from cold-adapted or wild-type … I Isakova-Sivak, D Korenkov, T Smolonogina, T Tretiak, S Donina, ... Virology 500, 209-217, 2017 | 27 | 2017 |
